160 related articles for article (PubMed ID: 9294836)
1. Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients.
Anderstam B; Katzarski K; Bergström J
J Am Soc Nephrol; 1997 Sep; 8(9):1437-42. PubMed ID: 9294836
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.
Kielstein JT; Böger RH; Bode-Böger SM; Schäffer J; Barbey M; Koch KM; Frölich JC
J Am Soc Nephrol; 1999 Mar; 10(3):594-600. PubMed ID: 10073610
[TBL] [Abstract][Full Text] [Related]
4. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure.
MacAllister RJ; Rambausek MH; Vallance P; Williams D; Hoffmann KH; Ritz E
Nephrol Dial Transplant; 1996 Dec; 11(12):2449-52. PubMed ID: 9017621
[TBL] [Abstract][Full Text] [Related]
5. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
[TBL] [Abstract][Full Text] [Related]
7. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantitative determination of N(G),N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry.
Di Gangi IM; Chiandetti L; Gucciardi A; Moret V; Naturale M; Giordano G
Anal Chim Acta; 2010 Sep; 677(2):140-8. PubMed ID: 20837180
[TBL] [Abstract][Full Text] [Related]
9. Symmetric dimethylarginine is an independent predictor of intradialytic hypotension.
Mangoni AA; Hewitson CL; Woodman RJ; Whiting MJ; McAteer-Carr B; Barbara JA
Am J Hypertens; 2008 Aug; 21(8):955-9. PubMed ID: 18551101
[TBL] [Abstract][Full Text] [Related]
10. Dimethylarginines in chronic renal failure.
Wahbi N; Dalton RN; Turner C; Denton M; Abbs I; Swaminathan R
J Clin Pathol; 2001 Jun; 54(6):470-3. PubMed ID: 11376022
[TBL] [Abstract][Full Text] [Related]
11. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
[TBL] [Abstract][Full Text] [Related]
12. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.
Tojo A; Welch WJ; Bremer V; Kimoto M; Kimura K; Omata M; Ogawa T; Vallance P; Wilcox CS
Kidney Int; 1997 Dec; 52(6):1593-601. PubMed ID: 9407505
[TBL] [Abstract][Full Text] [Related]
13. Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration.
Alkaitis MS; Nardone G; Chertow JH; Ackerman HC
Biomed Chromatogr; 2016 Mar; 30(3):294-300. PubMed ID: 26130049
[TBL] [Abstract][Full Text] [Related]
14. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.
Kato GJ; Wang Z; Machado RF; Blackwelder WC; Taylor JG; Hazen SL
Br J Haematol; 2009 May; 145(4):506-13. PubMed ID: 19344390
[TBL] [Abstract][Full Text] [Related]
15. The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels.
Uzun H; Konukoglu D; Besler M; Erdenen F; Sezgin C; Muderrisoglu C
Clin Invest Med; 2008; 31(1):E1-7. PubMed ID: 18312743
[TBL] [Abstract][Full Text] [Related]
16. Dimethylarginine levels and nutritional status in hemodialysis patients.
Cupisti A; Saba A; D'Alessandro C; Meola M; Panicucci E; Panichi V; Raffaelli A; Barsotti G
J Nephrol; 2009; 22(5):623-9. PubMed ID: 19809995
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
MacAllister RJ; Fickling SA; Whitley GS; Vallance P
Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
[TBL] [Abstract][Full Text] [Related]
18. Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC.
Teerlink T
Methods Mol Med; 2005; 108():263-74. PubMed ID: 16028689
[TBL] [Abstract][Full Text] [Related]
19. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
[TBL] [Abstract][Full Text] [Related]
20. [Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase].
Masuda H; Azuma H
Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):29-35. PubMed ID: 11862754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
